Претраживање
Приказ резултата 11-20 од 129
Opstruktivna apneja u snu i kardiometabolički rizik / Obstructive sleep apnea and cardiometabolic risk
(Beograd : Savez farmaceutskih udruženja Srbije, 2019)
Opstruktivna apneja u snu (OSA) je hronično progresivno oboljenje sa visokom prevalencom u populaciji koje, bez pravovremene dijagnoze i terapije, može dovesti do značajnih posledica po kvalitet života ...
Established and advanced adjuvants in vaccines' formulation: Mineral adsorbents, nanoparticulate carriers and microneedle delivery systems / Konvencionalni i napredni adjuvansi u formulacijama vakcina: mineralni adsorbenti, nanočestični nosači i sistemi tipa mikroigala
(Beograd : Savez farmaceutskih udruženja Srbije, 2019)
In the era of modern vaccinology, limited immunogenicity of the most commonly used antigens has enforced the use of various adjuvants in vaccine formulations to achieve desired immune response. Aluminum-containing ...
Clinical pharmacokinetics of methotrexate in the treatment of acute lymphoblastic leukemia and non-Hodgkin lymphoma in pediatric patients / Klinička farmakokinetika metotreksata u terapiji akutne limfoblastne leukemije i ne-Hodkinovog limfoma u pedijatrijskoj populaciji pacijenata
(Beograd : Savez farmaceutskih udruženja Srbije, 2020)
High dose methotrexate (MTX) is used in therapy of acute lymphoblastic leukemia and non-Hodgkin lymphoma in pediatric patients. It acts as competitive inhibitor of dihydrofolate reductase and consequently inhibits synthesis ...
The relationship between uric acid concentration and cardiovascular risk: Retrospective analysis of patients on hemodialysis / Povezanost koncentracije mokraćne kiseline sa tradicionalnim i ne-tradicionalnim faktorima rizika za kardiovaskularne bolesti kod bolesnika na hemodijalizi – retrospektivna analiza
(Beograd: Savez farmaceutskih udruženja Srbije, 2019)
Literature data indicate that increased uric acid (UA) levels are an important risk factor for cardiovascular disease. The aim of this study was to examine the association of UA with cardiovascular risk factors in patients ...
Hyaluronic acid in dermocosmetic products / Hijaluronska kiselina u dermokozmetičkim proizvodima
(Savez farmaceutskih udruženja Srbije, Beograd, 2009)
Hyaluronic acid is natural component of the skin. Due to its numerous functions and ability of water binding, hyaluronic acid influences skin hydration, keeps the moisture and elasticity of the skin and therefore it is ...
Bezbednosni aspekti primene biljnih proizvoda koji sadrže jedinjenja sa potencijalnim rizikom / Safety aspects of herbal products containing compounds with a potential risk
(Beograd : Savez farmaceutskih udruženja Srbije, 2019)
Pojedine biljne droge i preparati biljnih droga sadrže jedinjenja sa potencijalnim rizikom primene, kao što su pirolizidinski alkaloidi (npr. u korenu gaveza, Symphyti radix, listu podbela, Farfarae folium, rizomu lopuha, ...
Degradation kinetics and characterization of degradation products of losartan potassium by lc-ms/ms method / Kinetika degradacije i karakterizacija degradacionih proizvoda losartan kalijuma lcms/ms metodom
(Pharmaceutical Association of Serbia, 2019)
U ovom radu opisano je ispitivanje stabilnosti losartan kalijuma primenom tečne hromatografije sa UV i MS-MS detekcijom i prikazan je njegov profil degradacionih proizvoda. Rastvor losartan kalijuma bio je ...
Immunonephelometry and immunoturbidimetry: Theoretical principles, instruments and application / Imunonefelometrija i imunoturbidimetrija - teorijski principi, instrumenti i primena
(Savez farmaceutskih udruženja Srbije, Beograd, 2009)
Nephelometry and turbidimetry are methods based on the phenomenon whereby light, passing through a medium with dispersed particles is attenuated in intensity by scattering. The intensity of the scattered light is measured ...
Ambulatory treatment of arterial hypertension: The expenditures charged off health insurance funds / Farmakoterapija arterijske hipertenzije u ambulantnim uslovima - troškovi na godišnjem nivou na teret sredstava zdravstvenog osiguranja
(Savez farmaceutskih udruženja Srbije, Beograd, 2009)
Expenditures for the treatment of hypertension and its complication differ among countries and represent huge burden for National Health Funds. The aim of this study is to determine the expenditures charged off obligated ...
Characterization of orodispersible tablets and orodispersible films / Farmaceutsko-tehnološka karakterizacija oralno-disperzibilnih tableta i filmova
(Savez farmaceutskih udruženja Srbije, Beograd, 2018)
Orodispersible dosage forms are intended to be placed on tongue where, in contact with limited saliva volume, fast disintegration, followed by facilitated swallowing, occurred. Intraoral disintegration might be accompanied ...